Probiotics in non-alcoholic fatty liver disease: which and when
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 3
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently suggests that the microbiota is a casual factor of the disease, involved in the interactions between intestinal lumen and liver. Probiotic are commensal bacteria, able to modulate the microbiota with benefits for the health of humans. Several data suggest a range of potentially beneficial medicinal uses for probiotics, in particular in NAFLD patients. However, the species with higher efficacy in this disease are not identified. The present review focuses on the role of gut-liver axis in the pathogenesis, and on the potential therapeutic role of probiotics in the managing of NAFLD
Authors and Affiliations
Ludovico Abenavoli, Emidio Scarpellini, Samir Rouabhia, Clara Balsano, Francesco Luzza
Keywords
Related Articles
- EP ID EP78274
- DOI -
- Views 122
- Downloads 0
Effects of combined genes of CTLA4Ig and IDO in post-liver transplantation immune tolerance of rats
Background and rationale for the study. Previous studies showed that CTLA4Ig and indoleamine 2,3-dioxygenase (IDO) genes played regulatory role in organ transplantation but failed to reach satisfactory effects. In this...
Serum lipids and chronic hepatitis C genotype 4: interaction and significance
Background & aim. Metabolic abnormalities are common in chronic hepatitis C infection (CHC). However, the genotypic differences of these disarrangements in patients infected with CHC genotype 4 (HCV-4) and it...
Prolonged cholestasis triggered by hepatitis A virus infection and variants of the hepatocanalicular phospholipid and bile salt transporters
Hepatitis A virus (HAV) infection resolves in most patients uneventfully within weeks from the onset of the disease. In rare cases, however, it may relapse or cause prolonged cholestasis. Here we present a case of a 36-...
MDR3 mutations associated with intrahepatic and gallbladder cholesterol cholelithiasis: an update
Background: The recurrent microlithiasis represents one of the most frequent clinical forms of lithiasis of the bile ducts. This affection is characterized by the presence of cholesterolic microgallstones on hepatic cana...
Promotor methylation: Does it affect response to therapy in chronic Hepatitis C (G4) or fibrosis?
Background and aim. DNA methylation plays a critical role in the control of important cellular processes. The present study assessed the impact of promoter methylation (PM) of some genes on the antiviral response to anti...